
Abattis Bioceuticals Corp.
Share · CA00258G1037 (OTC)
No Price
Closing Price OTC 08.12.2025:
0,00003 USD
08.12.2025 21:00
Current Prices from Abattis Bioceuticals Corp.
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
UTC |
ATTBF
|
USD
|
08.12.2025 21:00
|
0,00003 USD
| 0,00 USD |
Company Profile for Abattis Bioceuticals Corp. Share
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Company Data
Name Abattis Bioceuticals Corp.
Company Abattis Bioceuticals Corp.
Website
https://www.abattis.com
Primary Exchange
UTC
ISIN CA00258G1037
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Francesco Paolini
Country Canada
Currency USD
Employees -
Address 625 Howe Street, V6C 2M6 Vancouver
IPO Date 2014-05-29
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ATTBF |
More Shares
Investors who hold Abattis Bioceuticals Corp. also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.



